Publication Name	World Journal of Hepatology
Manuscript ID	33022
Country	South Korea

Received	2017-02-04 09:42
Peer-Review Started	2017-02-12 15:56
To Make the First Decision	2017-03-08 09:39
Return for Revision	2017-03-09 16:37
Revised	2017-04-23 15:03
Second Decision	2017-05-11 12:25
Accepted by Journal Editor-in-Chief	2017-05-11 13:18
Accepted by Executive Editor-in-Chief	2017-05-19 03:55
Articles in Press	2017-05-19 03:55
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-06-01 01:23
Publish the Manuscript Online	2017-06-20 12:50

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Conventional vs drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma
Manuscript Source	Invited Manuscript
All Author List	Jeong Eun Song and Do Young Kim
Funding Agency and Grant Number
Corresponding Author	Do Young Kim, MD, Department of Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752, South Korea. dyk1025@yuhs.ac
Key Words	Hepatocellular carcinoma; Drug-eluting beads transarterial chemoembolization; Transarterial chemoembolization
Core Tip	Transarterial chemoembolization (TACE) is the current standard of therapy for patients with intermediate-stage hepatocellular carcinoma. Drug-eluting beads (DEBs) have been introduced as novel drug-delivery agents for TACE, allowing for higher concentrations of drugs to the target tumor and lower systemic concentrations, compared with conventional TACE (cTACE). Despite the theoretical advantages of DEB-TACE, whether DEB-TACE shows superior efficacy to cTACE remains controversial. Reviewing the literature, we found that DEB-TACE shows similar clinical outcomes to and fewer adverse events than cTACE.
Publish Date	2017-06-20 12:50
Citation	Song JE, Kim DY. Conventional vs drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma. World J Hepatol 2017; 9(18): 808-814
URL	http://www.wjgnet.com/1948-5182/full/v9/i18/808.htm
DOI	http://dx.doi.org/10.4254/wjh.v9.i18.808

Full Article (PDF)	WJH-9-808.pdf
Full Article (Word)	WJH-9-808.doc
Manuscript File	33022-Review.docx
Answering Reviewers	33022-Answering reviewers.pdf
Audio Core Tip	33022-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	33022-Conflict-of-interest statement.pdf
Copyright License Agreement	33022-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	33022-Language certificate.pdf
Peer-review Report	33022-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	33022-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	33022-Scientific misconduct check.pdf
Scientific Editor Work List	33022-Scientific editor work list.pdf